bioRxivCancer Biology
Ether lipid and sphingolipid expression patterns are G-protein coupled estrogen receptor 1-dependently altered in breast cancer cells
L. Hahnefeld, L. Gruber, N. Schoemel, C. Fischer, P. Mattjus, R. Gurke, M. Beretta, N. Ferreiros Bouzas, G. Geisslinger, M.-S. Wegner
Abstract
Identifying co-expression of lipid species is challenging, but indispensable to identify novel therapeutic targets for breast cancer treatment. Lipid metabolism is often dysregulated in cancer cells, and changes in lipid metabolism affect cellular processes such as proliferation, autophagy, and tumor development. In addition to mRNA analysis of sphingolipid metabolizing enzymes, we performed liquid chromatography time-of-flight mass spectrometry analysis in three breast cancer cell lines. These breast cancer cell lines differ in estrogen receptor and G-protein coupled estrogen receptor 1 status. Our data show that sphingolipids and non-sphingolipids are strongly increased in SKBr3 cells. SKBr3 cells are estrogen receptor negative and G-protein coupled estrogen receptor 1 positive. Treatment with G15, a G-protein coupled estrogen receptor 1 antagonist, abolishes the effect of increased sphingolipid and non-sphingolipid levels in SKBr3 cells. In particular, ether lipids are expressed at much higher levels in cancer compared to normal cells and are strongly increased in SKBr3 cells. Our analysis reveals that this is accompanied by increased sphingolipid levels such as ceramide, sphingadiene-ceramide and sphingomyelin. This shows the importance of focusing on more than one lipid class when investigating molecular mechanisms in breast cancer cells. Our analysis allows unbiased screening for different lipid classes leading to identification of co-expression patterns of lipids in the context of breast cancer. Co-expression of different lipid classes could influence tumorigenic potential of breast cancer cells. Identification of co-regulated lipid species is important to achieve improved breast cancer treatment outcome. HighlightsO_LILC-HRMS analysis allows identification of co-expression between lipid classes C_LIO_LIPutative co-expression of sphingolipid and non-sphingolipid classes C_LIO_LIEther lipids are strongly upregulated in SKBr3 cells (ER negative, GPER1 positive) C_LI
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolic shift to serine pathway induced by lipids confers oncogenic properties in non-transformed breast cells
M. B. Eduardo, G. Cottone, … S. E. Clare·bioRxiv·Feb 21, 2024
- Exposure of mammary cells to lipid activates gene expression changes associated with ER-negative breast cancer via chromatin remodeling.
- Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells
Ashley V. Ward, Duncan Riley, … Carol A. Sartorius·Breast Cancer ResearchPeer-reviewed·Mar 7, 2025
- Ether lipids influence cancer cell fate by modulating iron uptake
R. P. Mansell, S. Müller, … W. S. Henry·bioRxiv·Mar 20, 2024
- The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
U. Pal, M. C. Manjegowda, … A. M. Limaye·bioRxiv·Jun 14, 2022
- Endocytosis of very low-density lipoprotein particles: an unexpected mechanism for lipid acquisition by breast cancer cells
L. Lupien, K. Bloch, … W. Kinlaw·Journal of Lipid ResearchPeer-reviewed·Feb 1, 2020